Literature DB >> 18165857

Emergence of linezolid resistance in a methicillin resistant Staphylococcus aureus strain.

M Hentschke, B Saager, M A Horstkotte, S Scherpe, M Wolters, H Kabisch, R Grosse, P Heisig, M Aepfelbacher, H Rohde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18165857     DOI： 10.1007/s15010-007-7220-7

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

1.  Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.

Authors:  Carmen Betriu; Gracia Morales; Icíar Rodríguez-Avial; Esther Culebras; María Gómez; Fátima López-Fabal; Juan J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Emergence of linezolid-resistant mutants in a susceptible-cell population of methicillin-resistant Staphylococcus aureus.

Authors:  Yurika Ikeda-Dantsuji; Hideaki Hanaki; Taiji Nakae; Yoshio Takesue; Kazunori Tomono; Junichi Honda; Katsunori Yanagihara; Hiroshige Mikamo; Kunihiko Fukuchi; Mitsuo Kaku; Shigeru Kohno; Yoshihito Niki
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

3.  Evolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genome.

Authors:  Tetsuo Yamaguchi; Shingo Suzuki; Sakiko Okamura; Yuri Miura; Ayaka Tsukimori; Itaru Nakamura; Norihiko Ito; Anri Masuya; Takashi Shiina; Tetsuya Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

4.  In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.

Authors:  Alexander A Firsov; Maria V Golikova; Elena N Strukova; Yury A Portnoy; Andrey V Romanov; Mikhail V Edelstein; Stephen H Zinner
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

5.  Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus.

Authors:  Kyungae Lee; Jennifer Campbell; Jonathan G Swoboda; Gregory D Cuny; Suzanne Walker
Journal:  Bioorg Med Chem Lett       Date:  2010-01-20       Impact factor: 2.823

6.  Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents.

Authors:  Yangmei Li; Nina Bionda; Renee Fleeman; Hongjie Wang; Akihiko Ozawa; Richard A Houghten; Lindsey Shaw
Journal:  Bioorg Med Chem       Date:  2016-09-12       Impact factor: 3.641

7.  High-level expression, purification, and characterization of Staphylococcus aureus dihydroorotase (PyrC) as a cleavable His-SUMO fusion.

Authors:  Lena Truong; Kirk E Hevener; Amy J Rice; Kavankumar Patel; Michael E Johnson; Hyun Lee
Journal:  Protein Expr Purif       Date:  2012-12-13       Impact factor: 1.650

8.  Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.

Authors:  Helio S Sader; Thomas R Fritsche; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

9.  Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging.

Authors:  Anton Du Preez van Staden; Tiaan Heunis; Carine Smith; Shelly Deane; Leon M T Dicks
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 10.  The emerging problem of linezolid-resistant Staphylococcus.

Authors:  Bing Gu; Theodoros Kelesidis; Sotirios Tsiodras; Janet Hindler; Romney M Humphries
Journal:  J Antimicrob Chemother       Date:  2012-09-04       Impact factor: 5.758
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.